A Phase 2a Randomized, Doubled-Blind, Placebo-Controlled Trial to Evaluate Safety, Pharmacokinetics and Pharmacokinetic-Pharmacodynamic Relationships of RLS-0071 in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
view all Clinical Trials
Overview
The Phase 2 clinical trial will be a randomized, double-blind, placebo-controlled trial in hospitalized patients with AE-COPD. Patients will receive either RLS-0071 or placebo as an add-on to standard of care therapy.
Contact
For more information about this trial or to inquire about eligibility, email [email protected] or call 215-707-1359.